11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE decreases expression ISO RGD:1305967 6480464 Nevirapine metabolite results in decreased expression of CUX2 mRNA CTD PMID:23947594 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CUX2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1314310 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of CUX2 mRNA, [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17404688 , PMID:30165855 17beta-hydroxy-5alpha-androstan-3-one decreases expression EXP 6480464 Dihydrotestosterone results in decreased expression of CUX2 mRNA CTD PMID:17023530 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CUX2 mRNA CTD PMID:21889950 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1305967 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1314310 6480464 Tetrachlorodibenzodioxin affects the expression of CUX2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1314310 6480464 Tetrachlorodibenzodioxin results in decreased expression of CUX2 mRNA CTD PMID:19692669 , PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CUX2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CUX2 promoter] CTD PMID:17942748 , PMID:19654925 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1314310 6480464 3 more ... CTD PMID:19692669 8-bromo-3',5'-cyclic AMP decreases expression ISO RGD:1314310 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of CUX2 mRNA CTD PMID:22079614 aflatoxin B1 affects expression ISO RGD:1314310 6480464 Aflatoxin B1 affects the expression of CUX2 protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:1314310 6480464 Aflatoxin B1 results in increased methylation of CUX2 intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:1314310 6480464 Aflatoxin B1 results in decreased methylation of CUX2 gene CTD PMID:27153756 aflatoxin B2 decreases methylation ISO RGD:1314310 6480464 aflatoxin B2 results in decreased methylation of CUX2 intron CTD PMID:30157460 arsane affects methylation ISO RGD:1314310 6480464 Arsenic affects the methylation of CUX2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1314310 6480464 Arsenic affects the methylation of CUX2 gene CTD PMID:25304211 arsenic(3+) affects methylation ISO RGD:1314310 6480464 Arsenic affects the methylation of CUX2 gene CTD PMID:25304211 atrazine decreases expression ISO RGD:1314310 6480464 Atrazine results in decreased expression of CUX2 mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1314310 6480464 Benzo(a)pyrene results in decreased expression of CUX2 mRNA CTD PMID:20106945 benzo[a]pyrene affects methylation ISO RGD:1314310 6480464 Benzo(a)pyrene affects the methylation of CUX2 intron CTD PMID:30157460 benzo[e]pyrene increases methylation ISO RGD:1314310 6480464 benzo(e)pyrene results in increased methylation of CUX2 intron CTD PMID:30157460 bis(2-chloroethyl) sulfide increases expression EXP 6480464 Mustard Gas results in increased expression of CUX2 mRNA CTD PMID:15674843 bisphenol A increases methylation ISO RGD:1305967 6480464 bisphenol A results in increased methylation of CUX2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1305967 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene CTD PMID:28505145 bisphenol A affects methylation EXP 6480464 bisphenol A affects the methylation of CUX2 promoter CTD PMID:27334623 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon results in decreased expression of CUX2 mRNA CTD PMID:25620056 carmustine affects expression ISO RGD:1305967 6480464 Carmustine affects the expression of CUX2 mRNA CTD PMID:19174181 crocidolite asbestos decreases expression EXP 6480464 Asbestos, Crocidolite results in decreased expression of CUX2 mRNA CTD PMID:19446018 cyclosporin A decreases expression ISO RGD:1314310 6480464 Cyclosporine results in decreased expression of CUX2 mRNA CTD PMID:20106945 , PMID:27989131 diazinon increases methylation ISO RGD:1314310 6480464 Diazinon results in increased methylation of CUX2 gene CTD PMID:22964155 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CUX2 mRNA CTD PMID:21266533 dichloromethane decreases expression EXP 6480464 Methylene Chloride results in decreased expression of CUX2 mRNA CTD PMID:28392392 dorsomorphin multiple interactions ISO RGD:1314310 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1314310 6480464 Doxorubicin results in increased expression of CUX2 mRNA CTD PMID:29803840 endosulfan decreases expression ISO RGD:1305967 6480464 Endosulfan results in decreased expression of CUX2 mRNA CTD PMID:29391264 genistein multiple interactions ISO RGD:1305967 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of CUX2 gene CTD PMID:28505145 gentamycin decreases expression ISO RGD:1305967 6480464 Gentamicins results in decreased expression of CUX2 mRNA CTD PMID:22061828 indole-3-methanol multiple interactions ISO RGD:1305967 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA more ... CTD PMID:22129741 indole-3-methanol affects expression ISO RGD:1305967 6480464 indole-3-carbinol affects the expression of CUX2 mRNA CTD PMID:21396975 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of CUX2 mRNA CTD PMID:20003209 isotretinoin decreases expression ISO RGD:1314310 6480464 Isotretinoin results in decreased expression of CUX2 mRNA CTD PMID:20436886 lead nitrate multiple interactions EXP 6480464 lead nitrate affects the reaction [CUX2 affects the expression of MT1 mRNA], lead nitrate affects the reaction [CUX2 affects the expression of MT2 mRNA] CTD PMID:11891201 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CUX2 mRNA CTD PMID:12057914 methapyrilene increases methylation ISO RGD:1314310 6480464 Methapyrilene results in increased methylation of CUX2 intron CTD PMID:30157460 methylmercury chloride decreases expression ISO RGD:1314310 6480464 methylmercuric chloride results in decreased expression of CUX2 mRNA CTD PMID:28001369 morphine increases expression EXP 6480464 Morphine results in increased expression of CUX2 mRNA CTD PMID:21178816 N-acetyl-L-cysteine multiple interactions ISO RGD:1305967 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA, Acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CUX2 mRNA] CTD PMID:22129741 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of CUX2 intron CTD PMID:27776689 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1314310 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CUX2 mRNA CTD PMID:24810058 N-methyl-4-phenylpyridinium increases expression ISO RGD:1305967 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CUX2 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO RGD:1305967 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CUX2 mRNA more ... CTD PMID:22129741 nevirapine decreases expression ISO RGD:1305967 6480464 Nevirapine metabolite results in decreased expression of CUX2 mRNA CTD PMID:23947594 paracetamol decreases expression ISO RGD:1314310 6480464 Acetaminophen results in decreased expression of CUX2 mRNA CTD PMID:29067470 pentachlorophenol increases expression EXP 6480464 Pentachlorophenol results in increased expression of CUX2 mRNA CTD PMID:23892564 phenobarbital affects expression ISO RGD:1314310 6480464 Phenobarbital affects the expression of CUX2 mRNA CTD PMID:19159669 pirinixic acid multiple interactions ISO RGD:1314310 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CUX2 mRNA CTD PMID:19710929 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of CUX2 mRNA CTD PMID:20813756 , PMID:23811191 progesterone multiple interactions ISO RGD:1314310 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CUX2 mRNA CTD PMID:17404688 progesterone increases expression ISO RGD:1314310 6480464 Progesterone results in increased expression of CUX2 mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1314310 6480464 Progesterone results in decreased expression of CUX2 mRNA CTD PMID:18070364 quercetin increases expression ISO RGD:1305967 6480464 Quercetin results in increased expression of CUX2 mRNA CTD PMID:21565894 rotenone decreases expression ISO RGD:1314310 6480464 Rotenone results in decreased expression of CUX2 mRNA CTD PMID:29955902 SB 431542 multiple interactions ISO RGD:1314310 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 sodium arsenite decreases expression ISO RGD:1314310 6480464 sodium arsenite results in decreased expression of CUX2 mRNA CTD PMID:29301061 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CUX2 mRNA CTD PMID:25123088 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of CUX2 mRNA CTD PMID:17555576 titanium dioxide decreases expression ISO RGD:1305967 6480464 titanium dioxide results in decreased expression of CUX2 mRNA CTD PMID:30012374 trichostatin A increases expression ISO RGD:1314310 6480464 trichostatin A results in increased expression of CUX2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1314310 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1314310 6480464 trichostatin A results in decreased expression of CUX2 mRNA CTD PMID:24935251 , PMID:26272509 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of CUX2 mRNA CTD PMID:17963808 valproic acid affects expression ISO RGD:1314310 6480464 Valproic Acid affects the expression of CUX2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1314310 6480464 Valproic Acid results in decreased expression of CUX2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1314310 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CUX2 mRNA CTD PMID:27188386 valproic acid increases expression ISO RGD:1314310 6480464 Valproic Acid results in increased expression of CUX2 mRNA CTD PMID:23179753 more ...
Gene-Chemical Interaction Annotations
